AzTrials
AzTrials

AnisakisABCFish1NCT02661074

Anisakis Blastocystis Cryptosporidium Fish Prevalence

An observational study of Anisakis and Allergy, run by University Hospital, Lille at 3 sites in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Anisakidae frequently infect fish species that are commonly eaten by humans. Some of them are recognized as zoonotic agents, and have a high impact on human health. Infestation results from the ingestion of living larvae from contaminated fishes. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Anisakis, Allergy, Occupational Exposure
What is being tested?
Questionnaire
How many people
486 participants
Where
3 sitesFrance
Study dates
Nov 2014to Oct 2016
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Study population will include the following 3 groups: * Fishermen followed by the "Service de Santé des Gens de Mer" of Boulogne-sur-Mer, * Fish-processing factory workers followed by the "Service de Santé au Travail" of Boulogne-sur-Mer, * A control group composed of workers followed by the "Service de Santé au Travail" of Boulogne-sur-Mer, but not working in a fish-processing factory.

Who may be able to join

  • Fisherman followed by the "Service de Santé des Gens de Mer" of Boulogne-sur-Mer, fish-processing factory worker followed by the "Service de Santé au Travail" of Boulogne-sur-Mer, or worker followed by the "Service de Santé au Travail" of Boulogne-sur-Mer, but not working in a fish-processing factory.

Who cannot join

  • Pregnant or breast-feeding female
  • Patient with no social insurance
  • Patient unwilling to comply with the protocol
  • Patient unable to understand the study and its objectives
  • Patient under guardianship

Trial locations and contacts

3 sites in 1 country.

France3 sites
  • Centre ASTIL

    Boulogne-sur-Mer

  • Service de Santé des Gens de Mer

    Boulogne-sur-Mer

  • CHRU

    Lille

Other trials in France

About this study

Official title: Protists and Nematodes Fish Parasites: From Their Circulation in Ecosystems to Their Impact on Human Health - Prevalence of Fish Allergy in Occupational Settings.

Anisakidae frequently infect fish species that are commonly eaten by humans. Some of them are recognized as zoonotic agents, and have a high impact on human health.

Infestation results from the ingestion of living larvae from contaminated fishes. It can be asymptomatic or symptomatic, resulting in acute gastric, acute intestinal or chronic forms. Allergic manifestations are frequently encountered in gastric forms, but isolated allergic symptoms can occur after ingestion of Anisakidae antigens in raw or cooked fish. Cutaneous contact or Anisakis allergen inhalation have also been reported to induce allergy/anaphylactic reactions or sensitization in the occupational setting in Spain, Italy, Sicilia or South Africa. But no data is available in France.

In this context, the investigators propose to determine and compare the frequency and characteristics of fish allergy in fish workers (fishermen and fish-processing factory workers) and a control population of workers without occupational exposure to fish, in Boulogne-sur-Mer, which is an important fishing port in France, and the first European center for fish processing.

Read the detailed description

162 fishermen, 162 fish-processing factory workers, and 162 control subjects will be consecutively recruited by their occupational doctor during a routine consultation. A standardized questionnaire will be used to collect epidemiological and clinical data on potential allergic manifestation resulting from digestive, cutaneous, or respiratory contact with fish. Domestic and occupational risk factors for fish and Anisakis exposure will also be collected for both allergic and non-allergic patients.

Being tested
Questionnaire
Keywords
Fisherman, Fish industry
Medical subject headings
Anisakiasis, Hypersensitivity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • QuestionnaireOther

    A questionnaire will be completed in order to collect data on:

    • Potential allergic manifestations after fish contact: asthma, allergic rhinitis, conjunctivitis, chronic or acute urticaria, dermatitis/eczema, or severe allergic manifestations (angioedema, bronchospasm, anaphylaxis),
    • Occupational and/or domestic exposure to fish.
Study groups in NCT02661074
Study groupRoleWhat they receive
FishermenFisherman followed by the "Service de Santé des Gens de Mer" of Boulogne-sur-Mer, France (occupational exposure to fish). A questionnaire will be completed.
Receives: Other: Questionnaire
Fish processing factoriesWorkers of fish processing factories who are followed by the "Service de Santé au Travail" (ASTIL) of Boulogne-sur-Mer, France (occupational exposure to fish). A questionnaire will be completed.
Receives: Other: Questionnaire
ControlWorkers who are followed by the "Service de Santé au Travail" (ASTIL) of Boulogne-sur-Mer, France, but do not work in fish processing factories. A questionnaire will be completed.
Receives: Other: Questionnaire

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The prevalence of fish allergy

    Difference in the prevalence of fish allergy between occupationally exposed (fishermen and fish-processing factory workers) and non-exposed subjects.

    the fish allergy is definied by clinical diagnosis based on the presence of clinical manifestations of allergy in contact with the fish ( APC)

    Measured: contact by phone during 30 min at only visit (inclusion)

Secondary outcomes (4)
  1. Frequencies history of infections Anisakis spp.

    Comparison between occupationally exposed ( E: fishermen and fish-processing factory workers) and non-exposed subjects(NE)

    Measured: contact by phone during 30 min at only visit (inclusion)

  2. Frequency of fish allergies, history of infections Anisakis spp. (clinical diagnosis)

    comparison between occupationally exposed and non-exposed subjects for previous Anisakidosis.

    Fish exposure will be determined taking into account the handled fish species and the local prevalences of fish parasites.

    Measured: contact by phone during 30 min at only visit (inclusion)

  3. history of infections Anisakis spp. (clinical diagnosis)

    comparison between occupationally exposed and non-exposed subjects for previous Anisakidosis.

    Fish exposure will be determined taking into account the handled fish species and the local prevalences of fish parasites.

    Measured: contact by phone during 30 min at only visit (inclusion)

  4. Frequency of risk factors for occupational or domestic exposure to fish:

    comparison subjects (i) allergic or non-allergic Fish (APC + APC-vs) (ii) with or without a history of infection Anisakis spp. (IA + vs IA-).

    Measured: contact by phone during 30 min at only visit (inclusion)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Jan 2016 (estimated)
  2. Study startNov 2014
  3. Primary completionOct 2016
  4. Study completionOct 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
486 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02661074
Sponsor's protocol ID
2013_42
Other IDs
2014-A00853-44
Acronym
ABCFish1
Status last verified
Oct 2016
First submitted
13 Jan 2016
Last updated
14 May 2026
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Publications

  • Yera H, Frealle E, Dutoit E, Dupouy-Camet J. A national retrospective survey of anisakidosis in France (2010-2014): decreasing incidence, female predominance, and emerging allergic potential. Parasite. 2018;25:23. doi: 10.1051/parasite/2018016. Epub 2018 Apr 11.

    PubMed 29637891

Questions about this trial

What is this clinical trial studying?

An observational study of Anisakis and Allergy, run by University Hospital, Lille at 3 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The prevalence of fish allergy (time frame: contact by phone during 30 min at only visit (inclusion)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02661074, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in